Sanofi EBITDA 2010-2024 | SNY

Sanofi EBITDA for the quarter ending September 30, 2024 was $4.204B, a 20.02% increase year-over-year.

  • Sanofi 2023 EBITDA was 14.78B, a 3.18% increase from 2022.
  • Sanofi 2022 EBITDA was 14.324B, a 3.72% increase from 2021.
  • Sanofi 2021 EBITDA was 13.81B, a 32.95% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Sanofi EBITDA 2010-2024 | SNY

  • Sanofi 2023 EBITDA was 14.78B, a 3.18% increase from 2022.
  • Sanofi 2022 EBITDA was 14.324B, a 3.72% increase from 2021.
  • Sanofi 2021 EBITDA was 13.81B, a 32.95% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$790.2B
Novo Nordisk (NVO)$489.5B
Johnson & Johnson (JNJ)$373.3B
AbbVie (ABBV)$308.2B
Merck (MRK)$254.8B
Novartis AG (NVS)$216B
AstraZeneca (AZN)$200.9B
Pfizer (PFE)$148.7B
Innoviva (INVA)$1.3B